SEC Form 4 · accession 0001000229-17-000055
CORE LABORATORIES N V · CLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha Z. Carnes
Director
Period of report
Apr 1, 2017
Accepted (ET)
Apr 5, 2017 · 9:07 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000229
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted SharesF1 | $0.00 | Apr 1, 2017 | A | 1,299 | A | — | — | Common Shares | 1,299 | 1,299 | D |
Explanation of responses
- F1The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period ending April 1, 2018, subject to the terms of issuance.